Company intelligence / Profile preview

SOLA Pharmaceuticals

Baton Rouge, Louisiana, United Statessolameds.us ↗

Ownership: Private
Employees: ~49
Development stage: Commercial

Overview

SOLA Pharmaceuticals manufactures and distributes a portfolio of FDA-approved prescription and over-the-counter products in the US and Canada. Their focus includes topicals, injectables, patches, tablets, and IV solutions. All manufacturing occurs at cGMP-certified facilities with distribution from licensed centers in Louisiana (US) or Ontario (Canada). The company does not appear to have a drug development pipeline targeting specific diseases but rather supplies established generic pharmaceuticals[2][5][7][8].

Therapeutic areas: Other
Modalities: Small molecules (topicals, injectables, tablets)IV solutions
Industry: Biotech

Drug pipeline

1 asset

phenylephrine

Commercial

Indications: Ophthalmic conditions

Beyond the preview

Go deeper on SOLA Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SOLA Pharmaceuticals.

Explore the full profile